Brigitte Dreno

Summary

Country: France

Publications

  1. ncbi Hidradenitis suppurativa: the role of deficient cutaneous innate immunity
    Brigitte Dreno
    Institut National de la Santéet de la Recherche Médicale INSERM, U892, Centre de Recherche en Cancérologie Nantes Angers, France
    Arch Dermatol 148:182-6. 2012
  2. ncbi Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy
    Thomas Zuliani
    Cell and Gene Therapy Unit UTCG CIC biotherapy INSERM 0503 Hôtel Dieu University Hospital 44093 Nantes cedex 01 France
    J Transl Med 9:63. 2011
  3. ncbi Management of skin ageing: how to combine cosmetic procedures
    Brigitte Dreno
    Unité de Cancérologie Cutanée, Hotel Dieu, Place Alexis Ricordeau, Nantes Cedex 01, France
    Eur J Dermatol 18:444-51. 2008
  4. ncbi Large-scale worldwide observational study of adherence with acne therapy
    Brigitte Dreno
    Department of Dermatolgy, Nantes University Hospital, Hotel Dieu, Nantes, France
    Int J Dermatol 49:448-56. 2010
  5. ncbi Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe
    B Dreno
    Department of Cancero Dermatology, Hotel Dieu, Nantes Cedex, France
    J Eur Acad Dermatol Venereol 25:43-8. 2011
  6. ncbi Innate immunity: a crucial target for zinc in the treatment of inflammatory dermatosis
    A Brocard
    Skin Cancer Unit, Nantes University Hospital, Nantes, France
    J Eur Acad Dermatol Venereol 25:1146-52. 2011
  7. ncbi Topical antibacterial therapy for acne vulgaris
    Brigitte Dreno
    Department of Dermatology, Hotel Dieu, Nantes, France
    Drugs 64:2389-97. 2004
  8. ncbi [Anatomy and physiology of skin and cutaneous annexes]
    B Dreno
    CHU de Nantes, Clinique Dermatologique, Place Alexis Ricordeau, Nantes Cedex 1, France
    Ann Dermatol Venereol 136:S247-51. 2009
  9. ncbi Combined 0.1% retinaldehyde/ 6% glycolic acid cream in prophylaxis and treatment of acne scarring
    Brigitte Dreno
    A Sygros Hospital, University of Athens, Athens, Greece
    Dermatology 214:260-7. 2007
  10. ncbi European recommendations on the use of oral antibiotics for acne
    Brigitte Dreno
    Department of Dermatology, Hotel Dieu, Place Alexis Ricordeau, 44093 Nantes Cedex 01, France
    Eur J Dermatol 14:391-9. 2004

Collaborators

Detail Information

Publications110 found, 100 shown here

  1. ncbi Hidradenitis suppurativa: the role of deficient cutaneous innate immunity
    Brigitte Dreno
    Institut National de la Santéet de la Recherche Médicale INSERM, U892, Centre de Recherche en Cancérologie Nantes Angers, France
    Arch Dermatol 148:182-6. 2012
    ..To evaluate the expression of innate immunity markers at the site of nodules caused by hidradenitis suppurativa (HS)...
  2. ncbi Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy
    Thomas Zuliani
    Cell and Gene Therapy Unit UTCG CIC biotherapy INSERM 0503 Hôtel Dieu University Hospital 44093 Nantes cedex 01 France
    J Transl Med 9:63. 2011
    ..To address these problems we developed a specific compartmentalised bag allowing efficient expansion of tumour-specific T lymphocytes in an easy handling, closed system...
  3. ncbi Management of skin ageing: how to combine cosmetic procedures
    Brigitte Dreno
    Unité de Cancérologie Cutanée, Hotel Dieu, Place Alexis Ricordeau, Nantes Cedex 01, France
    Eur J Dermatol 18:444-51. 2008
    ..This therapeutic strategy is based both on an analysis of the literature and the personal experience of the experts...
  4. ncbi Large-scale worldwide observational study of adherence with acne therapy
    Brigitte Dreno
    Department of Dermatolgy, Nantes University Hospital, Hotel Dieu, Nantes, France
    Int J Dermatol 49:448-56. 2010
    ....
  5. ncbi Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe
    B Dreno
    Department of Cancero Dermatology, Hotel Dieu, Nantes Cedex, France
    J Eur Acad Dermatol Venereol 25:43-8. 2011
    ..Many acne grading methods exist; however, there is no agreed-upon standard. Our objective was to create and validate a reproducible acne assessment scale for rating the severity of juvenile facial acne suitable for use in France and Europe...
  6. ncbi Innate immunity: a crucial target for zinc in the treatment of inflammatory dermatosis
    A Brocard
    Skin Cancer Unit, Nantes University Hospital, Nantes, France
    J Eur Acad Dermatol Venereol 25:1146-52. 2011
    ..It has been shown by different data that it could play a crucial role not only in the regulation of adaptative immunity but also in innate immunity which plays a crucial role in skin...
  7. ncbi Topical antibacterial therapy for acne vulgaris
    Brigitte Dreno
    Department of Dermatology, Hotel Dieu, Nantes, France
    Drugs 64:2389-97. 2004
    ..Topical and oral antibacterials should not be used in combination for the treatment of acne vulgaris, since this association may increase the risk of bacterial resistance...
  8. ncbi [Anatomy and physiology of skin and cutaneous annexes]
    B Dreno
    CHU de Nantes, Clinique Dermatologique, Place Alexis Ricordeau, Nantes Cedex 1, France
    Ann Dermatol Venereol 136:S247-51. 2009
    ....
  9. ncbi Combined 0.1% retinaldehyde/ 6% glycolic acid cream in prophylaxis and treatment of acne scarring
    Brigitte Dreno
    A Sygros Hospital, University of Athens, Athens, Greece
    Dermatology 214:260-7. 2007
    ..Acne often results in permanent, badly tolerated, difficult to treat scars...
  10. ncbi European recommendations on the use of oral antibiotics for acne
    Brigitte Dreno
    Department of Dermatology, Hotel Dieu, Place Alexis Ricordeau, 44093 Nantes Cedex 01, France
    Eur J Dermatol 14:391-9. 2004
    ..Recommendations cover optimal choice of antibiotic, drug doses, duration of treatment, combination treatment, and maintenance therapy...
  11. ncbi [Pathophysiology of acne]
    Brigitte Dreno
    Service de Dermatologie, Hotel Dieu, Place Alexis Ricordeau, 44093 Nantes Cedex 01
    Presse Med 34:537-9. 2005
    ..This finding provides physiological support to the clinical observation that stress can induce acne...
  12. ncbi [The treatment of acne]
    Brigitte Dreno
    Service de Dermatologie, Hotel Dieu, Place Alexis Ricordeau, 44093 Nantes Cedex 01
    Presse Med 34:540-3. 2005
    ..Zinc, which basically targets inflammatory acne, is a possible option for pregnant women and during the summer. Cosmetic care is also a fundamental part of acne treatment...
  13. ncbi Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study
    Brigitte Dreno
    Department of Dermatology, CHU Nantes, 44035 Nantes Cedex 01, France
    Eur J Dermatol 15:152-5. 2005
    ..Thus, association of zinc salts via a systemic route and topical erythromycin treatment seems an interesting option in the light of an increasing number of patients carrying erythromycin resistant Propionibacterium acnes strains...
  14. ncbi Standard and new treatments in cutaneous B-cell lymphomas
    Brigitte Dreno
    Department of Dermatology, CHU Hotel Dieu, Nantes, France
    J Cutan Pathol 33:47-51. 2006
    ..The aim of this paper is to perform a review of standard and new treatments. Method: This paper provides a literature review of the different treatments of PCBCL...
  15. ncbi Assessing quality of life in patients with acne vulgaris: implications for treatment
    Brigitte Dreno
    Department of Dermatology, Hotel Dieu, Nantes, France
    Am J Clin Dermatol 7:99-106. 2006
    ..Finally, there are now validated quality of life scales that are easy to use during patient consultations (taking <2 minutes to complete) by clinicians wishing to evaluate quality of life in patients with acne...
  16. ncbi Interest of the association retinaldehyde/glycolic acid in adult acne
    B Dreno
    Department of Dermatology, CHU Nantes, France
    J Eur Acad Dermatol Venereol 23:529-32. 2009
    ..The aim of this study was to evaluate the tolerance and the efficiency of RAL (0.1%)/GA (6%) in adult women with acne when used alone or in combination with their usual acne products except retinoids...
  17. ncbi Acne: evolution of the clinical practice and therapeutic management of acne between 1996 and 2000
    Brigitte Dreno
    Acne Research and Study Group GREA, Dermatology Department, Nantes University Hospital Center, Place Alexis Ricordeau, France
    Eur J Dermatol 13:166-70. 2003
    ..The profile of acne patients evolved slightly between 1996 and 2000 and interestingly the treatments were modified to take into account the information in the literature such as bacterial resistance or severe side effects...
  18. ncbi [Immunotherapy of melanoma]
    Brigitte Dreno
    Dermato cancérologie, Unité thérapie cellulaire et génique, CHU Nantes, Place Alexis Ricordeau 44093 cedex 01
    Bull Acad Natl Med 194:1373-81. 2010
    ..If these treatments are to realize their full potential, it will be essential to understand how the tumor induces immune tolerance...
  19. ncbi Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study
    B Dreno
    Hopital Hotel Dieu, Department of Dermato Oncology, Place Alexis Ricordeau, 44093 Nantes Cedex 1, France
    Br J Dermatol 165:383-90. 2011
    ..Oral antibiotics in association with a topical retinoid with or without benzoyl peroxide (BPO) are the recommended first-line option in the treatment of moderate to severe acne vulgaris...
  20. ncbi [A therapeutic algorithm in acne: why?]
    B Dreno
    Clinique Dermatologique, CHU Hotel Dieu, Place Alexis Ricordeau, 44093 Nantes Cedex 01, France
    Ann Dermatol Venereol 137:S66-8. 2010
    ....
  21. ncbi [Recent data on epidemiology of acne]
    B Dreno
    Clinique Dermatologique, CHU Hotel Dieu, Place Alexis Ricordeau, 44093 Nantes Cedex 01, France
    Ann Dermatol Venereol 137:S49-51. 2010
    ..Actually, acne is regarded today as a chronic disease requiring treatment of induction and maintenance...
  22. ncbi Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones
    Amir Khammari
    Skin Cancer Unit, Nantes CHU, Nantes, cedex 01 44093, France
    J Invest Dermatol 129:2835-42. 2009
    ..Thus, over the course of an adoptive cell transfer, monitoring this melanoma-specific T-cell expansion in patient blood appears crucial for predicting the clinical efficiency of such an immunological approach...
  23. ncbi Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy
    Yann Godet
    UMR INSERM U892, CRCNA, Nantes, France
    Eur J Immunol 40:1786-94. 2010
    ..This study documents the existence of a large TCR repertoire specific for the MELOE-1/A2 epitope and its capacity to give rise to antitumor CTL that supports the development of immunotherapies targeting this epitope...
  24. ncbi Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients
    Houssem Benlalam
    INSERM U601, 9 quai Moncousu, 44093, Nantes Cedex 1, France
    Cancer Immunol Immunother 56:515-26. 2007
    ..These results further support the relevance of Melan-A/MART-1 antigen as a prime target for immunotherapy protocols in melanoma...
  25. ncbi A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients
    Yann Godet
    INSERM U892, 9 quai Moncousu, 44093, Nantes Cedex 1, France
    Cancer Immunol Immunother 58:271-80. 2009
    ..Our data show that this nonapeptide is a new tool that could be used to generate melanoma-specific T cells for adoptive immunotherapy or serve as a peptide vaccine for HLA-B*4002 melanoma patients...
  26. ncbi Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma
    Amir Khammari
    Skin Cancer Unit, CHU Hotel Dieu, Nantes, Place Alexis Ricordeau, 44093, Nantes Cedex 01, France
    Cancer Immunol Immunother 56:1853-60. 2007
    ....
  27. ncbi Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metastatic melanoma
    Anne C Knol
    INSERM, U892, CRCNA, Nantes, France
    Exp Dermatol 20:430-4. 2011
    ..High Foxp3 expression might thus enable the identification of patients most at risk of relapse...
  28. ncbi Melanoma gene expression and clinical course
    M Vourc'h-Jourdain
    Unit of Skin Cancer Nantes University Hospital, Nantes, France
    Arch Dermatol Res 301:673-9. 2009
    ..However, with regard to certain sub-groups, such as stage III samples, tumour gene expression was significantly associated with survival...
  29. ncbi Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants
    Gaelle Quereux
    Nantes University Hospital, INSERM, Nantes, France
    Acta Derm Venereol 90:616-20. 2010
    ..Only eight cases of cutaneous lymphomas associated with treatment with TNF-? blockers have been published previously. Most of these eight cases related to anti-TNF? antibodies; only two were linked to etanercept...
  30. ncbi Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells
    Virginie Vignard
    , Nantes, France
    J Immunol 175:4797-805. 2005
    ..Together, our results suggest that infused CTL clones may have initiated an antitumor response that may have resulted in the expansion of a Melan-A-specific CTL repertoire...
  31. ncbi A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes
    Régis Bouquié
    INSERM U892, 9 quai Moncousu, 44093, Nantes Cedex 1, France
    Cancer Immunol Immunother 58:553-66. 2009
    ..Altogether, these new multimers fulfill all the necessary requirements to select clinical grade T lymphocytes and should facilitate the development of ACT protocols in cancer patients...
  32. ncbi Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation
    Olivia Isard
    INSERM U892, 9 quai Moncousu, Nantes, France
    J Invest Dermatol 131:59-66. 2011
    ..These observations were confirmed at the mRNA level for IGF-1R in NHEKs. These results demonstrate that P. acnes can induce the formation of comedones by stimulating the IGF/IGF-1R system. Moreover, zinc downregulates this pathway...
  33. ncbi Development of an individual score for melanoma risk
    Gaelle Quereux
    Skin Cancer Unit, INSERM, Nantes University Hospital, Nantes Cedex, France
    Eur J Cancer Prev 20:217-24. 2011
    ..It can be assessed without any computer or calculator and is based on the self-assessment of the melanoma risk factors by the patient and thus is not medical time consuming...
  34. ncbi Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas
    Juliette Desfrançois
    UMR INSERM, U892, Nantes, France
    PLoS ONE 5:e8437. 2010
    ..This manuscript addresses the question of the existence and above all the role of this non-conventional DP sub-population among tumor associated lymphocytes in melanomas...
  35. ncbi TLR expression in human melanoma cells
    Mélanie Saint-Jean
    Immuno dermatology laboratory, Onco dermatology unit, CIC biothérapie INSERM 0503, CHU Hotel Dieu, 1 place A Ricordeau, 44093 Nantes Cedex 1, France
    Eur J Dermatol 21:899-905. 2011
    ..TLR-7 and -9 proteins were expressed ex vivo and in vitro. Our study demonstrates for the first time that melanoma cells express TLR7 and -8...
  36. ncbi Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study
    Anabelle Brocard
    Department of Dermatology, INSERM U601, CHU Hotel Dieu, Nantes, France
    Dermatology 214:325-7. 2007
    ..Hidradenitis suppurativa (Verneuil's disease) is a chronic suppurative dermatosis involving apocrine glands with a severe impact on the quality of life, which is enhanced by the fact that the drugs usually prescribed are poorly effective...
  37. ncbi [Treatment of melanoma]
    Brigitte Dreno
    Unité de cancéro dermatologie, Clinique Dermatologique, CHU Hotel Dieu, Nantes
    Presse Med 32:39-43. 2003
    ..Although clinical results are starting to be published, cellular immunotherapy remains in the field of clinical research, within the framework of clinical trials...
  38. ncbi Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome
    Gaelle Quereux
    Departments of Dermatology, Centre Hospitalier Universitaire, Nantes, France
    Arch Dermatol 144:727-33. 2008
    ..To assess the rate of objective response to pegylated liposomal doxorubicin hydrochloride (Caelyx) in patients with advanced or refractory cutaneous T-cell lymphoma (CTCL)...
  39. ncbi Prospective trial on a school-based skin cancer prevention project
    Gaelle Quereux
    Unit of Skin Cancer, Nantes University Hospital, INSERM 892, Nantes, France
    Eur J Cancer Prev 18:133-44. 2009
    ..The programme had a beneficial effect on the children's knowledge persisting for at least a few months but had no impact on their behaviour towards the sun...
  40. ncbi Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo
    Brigitte Dreno
    CHU Nantes, Clinique Dermatologique, Hotel Dieu, BP 1005, 44035 Nantes Cedex, France
    Eur J Dermatol 12:549-52. 2002
    ..3% and 29.1% of the patients in the lithium group, and 5.1% and 3.8% respectively in the placebo group. This study confirms the effectiveness of 8% lithium gluconate ointment in the treatment of seborrhoeic dermatitis...
  41. ncbi alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen
    Emmanuelle Godefroy
    Institut National de la Sante et de la Recherche Medicale, Unite 601, Nantes, France
    J Exp Med 202:61-72. 2005
    ..Because MMP-2 activity is critical for melanoma progression, the MMP-2 peptide should be cross-presented by most progressing melanomas and represents a unique antigen for vaccine therapy of these tumors...
  42. ncbi Localized scleroderma and zinc: a pilot study
    Anabelle Brocard
    Unit of Skin Cancer, Nantes University Hospital, Place Alexis Ricordeau 44093 Cedex 01 Nantes, France
    Eur J Dermatol 20:172-4. 2010
    ..We conclude that high-dose zinc gluconate can therefore be a valuable alternative treatment for localized scleroderma, with good tolerability, although placebo-controlled studies are necessary to confirm our results...
  43. ncbi Creation and test of a questionnaire for self-assessment of melanoma risk factors
    Gaelle Quereux
    Skin Cancer Unit, INSERM, Nantes University Hospital, Nantes Cedex, France
    Eur J Cancer Prev 19:48-54. 2010
    ..Furthermore, self-screening with the self-assessment questionnaire is easily feasible and is accurate for identifying high-risk individuals. This tool might be useful for carrying out melanoma-targeted screening...
  44. ncbi Routine bone marrow biopsy in the initial evaluation of primary cutaneous B-cell lymphoma does not appear justified
    Gaelle Quereux
    Dermatology Department, Nantes University Hospital Center, Place Alexis Ricordeau, 44093 Nantes, France
    Eur J Dermatol 19:216-20. 2009
    ..In conclusion, this study demonstrates that it is not indispensable to perform a routine BMB for a Primary cutaneous B-cell lymphoma with cutaneous lesions on examination and with negative CT Scan and blood laboratory evaluations...
  45. ncbi Systemic rituximab in multifocal primary cutaneous follicle centre lymphoma
    Gaelle Quereux
    Skin Cancer Unit, Nantes University Hospital, INSERM, Nantes, France
    Acta Derm Venereol 91:562-7. 2011
    ..This study is the largest series of patients with multifocal primary PCFCL treated with intravenous rituximab. This therapy is a safe and effective treatment and could represent an excellent alternative treatment to radiotherapy...
  46. ncbi Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene
    Anne Chantal Knol
    INSERM, U892, Nantes Cedex 01, France
    Exp Dermatol 19:e95-102. 2010
    ..The treatment with bexarotene does not seem to affect the regulatory T-cell compartment...
  47. ncbi Fotemustine for the treatment of melanoma
    Gaelle Quereux
    Nantes University Hospital, Skin Cancer Unit, INSERM 892, 1 Place Alexis Ricordeau, 44093 Nantes Cedex, France
    Expert Opin Pharmacother 12:2891-904. 2011
    ..However, overall response rates are low, with only few complete remissions and short response durations...
  48. ncbi Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis
    F Ballanger
    Department of Dermatology, CHU Hotel Dieu, Nantes Cedex 01, France
    Arch Dermatol Res 300:215-23. 2008
    ..The diminution of TLR2 expression by Li may not allow MF to trigger inflammation response in lesional skin...
  49. ncbi [Specificity of acne in women older than 25 years]
    Gwenaelle Dumont-Wallon
    Clinique Dermatologique, CHU Hotel Dieu, F 44000, Nantes, France
    Presse Med 37:585-91. 2008
    ..Our aim was to examine the specific clinical and therapeutic characteristics of acne in women seen in our practice...
  50. ncbi Evaluation of the role of human herpes virus 6 and 8 in parapsoriasis
    Gaelle Quereux
    Skin Cancer Unit, Nantes University Hospital, Nantes, France
    Exp Dermatol 18:357-61. 2009
    ..Previous recent studies have suspected the involvement of viral agents and particularly human herpes viruses (HHV).The aim of the present study was to screen for the presence of HHV-6 and HHV-8 genome in parapsoriasis samples...
  51. ncbi CD8(+) T lymphocytes reactive against Epstein-Barr virus antigens in skin lesions of a patient with Sézary syndrome
    Anne-Chantal Knol
    , Nantes, France
    J Am Acad Dermatol 53:897-900. 2005
    ..This is, to our knowledge, the first description of the presence of EBV-specific T lymphocytes among tumor-infiltrating lymphocytes infiltrating the lesional skin of a patient with Sézary syndrome...
  52. ncbi Impact of a campaign to train general practitioners in screening for melanoma
    Lucie Peuvrel
    Réseau Mélanome Ouest, Dermatological Clinic, Nantes University Hospital Center, Nantes, France
    Eur J Cancer Prev 18:225-9. 2009
    ..As a result, after a short prior training, the ABCDE rule clearly seems to be a valuable tool. Dermatologists retain an important role both in the diagnostic confirmation of melanomas and in the training of general practitioners...
  53. ncbi The Cardiff Acne Disability Index: cultural and linguistic validation in French
    Brigitte Dreno
    Department of Dermatology Hôtel Dieu, Nantes, France
    Dermatology 208:104-8. 2004
    ..The Cardiff Acne Disability Index (CADI) evaluates the impact of acne on the patient's life...
  54. ncbi Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer
    Mathilde Allard
    UMR INSERM, U892, Nantes, France
    PLoS ONE 6:e21118. 2011
    ..In order to investigate sHLA-E production by various tumors and to address its potential value as a tumor-associated marker, we developed a specific ELISA for the quantification of sHLA-E in biological fluids...
  55. ncbi Temozolomide associated with PEG-interferon in patients with metastatic melanoma: a multicenter prospective phase I/II study
    Bernard Guillot
    Department of Dermatology, Hopital Saint Eloi, University of Montpellier I, Montpellier, France
    Melanoma Res 18:141-6. 2008
    ..At a lower level, this treatment was effective and deserves further investigations to define its indications in metastatic melanoma patients...
  56. ncbi Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type
    Marion Fenot
    Department of Dermato Oncology, Nantes University Hospital Centre, Nantes Cedex, France
    Eur J Dermatol 20:753-7. 2010
    ..The tolerance of rituximab monotherapy is higher than rituximab with polychemotherapy. The risk-benefit ratio is a bit lower but rituximab is well tolerated and may be useful for short term palliative treatment...
  57. ncbi Is antigen specificity the key to efficient adoptive T-cell therapy?
    Nathalie Labarriere
    Unite Mixte de Recherche Institut National de la Sante et de la Recherche Medicale, Unite 892, Centre de Recherche en Canerologie Nantes Angers, Nantes, France
    Immunotherapy 3:495-505. 2011
    ..Future improvements of adoptive melanoma immunotherapy may be achieved by its association with other therapeutic strategies such as targeted therapy against signaling pathways...
  58. ncbi A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study
    Pascal Joly
    Department of Dermatology, INSERM U901, University of Rouen, Rouen, France
    J Invest Dermatol 129:1681-7. 2009
    ..54; 95% confidence interval, 0.30-0.97; P=0.039). This mild regimen allows a 70% reduction of the cumulative doses of CS and improves BP patients' outcome...
  59. ncbi Gluten intolerance and skin diseases
    Philippe Humbert
    Department of Dermatology, University of Franche Comte, CHU Saint Jacques, 25030 Besancon, France
    Eur J Dermatol 16:4-11. 2006
    ..Intestinal biopsy is usually needed to establish the diagnosis of CD or GI. Thus, gluten intolerance gives rise to a variety of dermatological manifestations which may benefit from a gluten-free diet...
  60. ncbi Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes
    Véronique Jarrousse
    INSERM U601, 9, quai Moncousu, 44093, Nantes Cedex 01, France
    Eur J Dermatol 17:492-6. 2007
    ..However, this inhibition does not modify IL-8 secretion by keratinocytes. In conclusion the inhibition of TLR2 surface expression by keratinocytes could be one of the anti-inflammatory mechanisms of zinc salts in acne...
  61. ncbi In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions
    Isabelle Tenaud
    Department of Dermatology, CHU, Nantes, France
    Exp Dermatol 16:500-6. 2007
    ..The decreased expression of TLR-2 by the keratinocytes can contribute to explain the anti-inflammatory activity of adapalene observed in clinical practice...
  62. ncbi [Treatment of primary and regional melanoma]
    Brigitte Dreno
    CHRU de Nantes, unité de cancérologie dermatologique, Hotel Dieu, 44093 Nantes 1
    Rev Prat 54:1203-9. 2004
    ..Chemotherapy on the other hand never proved reliable of its effectiveness as adjuvant treatment. In the future, the approaches by vaccination and cellular therapy could be interesting at these stages of the disease...
  63. ncbi Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma
    Brigitte Dreno
    Skin Cancer Unit, CHR Hotel Dieu, Nantes, 44093 Nantes, France
    Cancer Immunol Immunother 51:539-46. 2002
    ....
  64. ncbi [General antibiotic therapy in acne]
    Brigitte Dreno
    Clinique dermatologique Centre hospitalier universitaire Hôtel Dieu, 44093 Nantes
    Rev Prat 52:841-3. 2002
    ..Resistant strains of Propionibacterium acnes to antibiotics are increasing. Thus, general guidelines are useful when utilizing oral antibiotic therapy in acne...
  65. ncbi Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study
    B Dreno
    Clinique Dermatologique, CHU Nantes, Hotel Dieu, BP 1005, 44305 Nantes Cedex, France
    Br J Dermatol 148:1230-6. 2003
    ..Objectives This randomized controlled trial was designed to show a non-inferiority of 15% (primary end-point) of lithium gluconate 8% ointment compared with ketoconazole 2% emulsion...
  66. ncbi [Acne scars: epidemiology, physiopathology, clinical features and treatment]
    M Chivot
    Ann Dermatol Venereol 133:813-24. 2006
  67. ncbi ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology
    B Dreno
    Clinique Dermatologique, CHU, Nantes, France
    Dermatology 214:46-51. 2007
    ..The ECCA grading scale (échelle d'évaluation clinique des cicatrices d'acné) is a tool designed to help dermatologists to assess the severity of acne scars and to standardize the discussions about the treatments of scars...
  68. ncbi [Clinical and psychological correlation in acne: use of the ECLA and CADI scales]
    B Dreno
    Departement de Dermatologie, CHU Nantes, Hotel Dieu, Nantes, France
    Ann Dermatol Venereol 134:451-5. 2007
    ..The purpose of this study was to use both of these scales in individual applications in order to determine whether or not any correlation exists between the two specific tools and to determine the two groups of patients affected by acne...
  69. ncbi [Interferons and malignant melanoma]
    B Dreno
    Service de Dermatologie, Hotel Dieu, Place Alexis Ricordeau, 44093 Nantes, France
    Rev Med Interne 23:489s-493s. 2002
    ..In addition, the future use of pegylated interferon which would permit a reduction in the number of injections is of a significant interest...
  70. ncbi [Lithium gluconate 8% in the treatment of seborrheic dermatitis]
    B Dreno
    Departement de Dermatologie, CHU de Nantes, 44035 Nantes Cedex
    Ann Dermatol Venereol 134:347-51. 2007
    ..Lithioderm 8% gel is applied twice daily over a recommended period of 2 months. It constitutes a new alternative in the treatment of facial seborrheic dermatitis, regardless of severity...
  71. ncbi Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients
    B Dreno
    Department of Dermatology, CHU Nantes, Nantes, France
    Dermatology 210:22-9. 2005
    ..The aim of this study was to evaluate the tolerance of Diacneal used by 1,709 acne patients in combination with their usual acne products except retinoids...
  72. ncbi Effect of selenium intake on the prevention of cutaneous epithelial lesions in organ transplant recipients
    B Dreno
    CHU Nantes, Clinique Dermatologique, Hotel Dieu, BP 1005, 44305 Nantes Cedex, France
    Eur J Dermatol 17:140-5. 2007
    ..This was demonstrated by the high rate of epithelial lesions detected, which was more than twice the rate usually reported in the literature...
  73. ncbi [Acne, pregnant women and zinc salts: a literature review]
    B Dreno
    Clinique Dermatologique, Hotel Dieu, CHU de Nantes, Place Alexis Ricordeau, 44035 Nantes, France
    Ann Dermatol Venereol 135:27-33. 2008
    ....
  74. ncbi Zinc gluconate is an agonist of peroxisome proliferator-activated receptor-? in the epidermis
    Carole Poiraud
    INSERM U892, Nantes University Hospital, Nantes, France Department of Dermato Oncology, Nantes University Hospital, Nantes, France Private Statistical Consultant, Nantes, France
    Exp Dermatol 21:347-51. 2012
    ..These results suggest that zinc gluconate may be a PPAR-? agonist, which might play a role in the anti-inflammatory activity of this molecule...
  75. ncbi Ex vivo demonstration of a synergistic effect of Adapalene and benzoyl peroxide on inflammatory acne lesions
    Thomas Zuliani
    Laboratory of Immuno Dermatology, CIC biotherapy INSERM 0503, University Hospital, Nantes, France Unit of Dermato Cancerology, CHU de Nantes, CIC biotherapy INSERM 0503, University Hospital, Nantes, France
    Exp Dermatol 20:850-3. 2011
    ..These results contribute to explain the comedolytic and anti-inflammatory activities of this combined therapy observed in recent clinical trials...
  76. ncbi Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes
    Houssem Benlalam
    , Nantes, France
    J Immunol 171:6283-9. 2003
    ..These data have important implications for the formulation of polypeptide-based vaccines as well as for the monitoring of melanoma-specific CTL response in HLA-B*3501 melanoma patients...
  77. ncbi Epidemiology of acne
    Brigitte Dreno
    Department of Dermatology, Hospital Hotel Dieu, Nantes, France
    Dermatology 206:7-10. 2003
  78. ncbi Skin cancers after transplantation
    Brigitte Dreno
    Centre Hospitalier Universitaire, Clinique Dermatologique, Nantes, France
    Nephrol Dial Transplant 18:1052-8. 2003
  79. ncbi [Epidemiology of melanoma]
    Brigitte Dreno
    Unité de cancéro dermatologie, Clinique Dermatologique, CHU Hotel Dieu, Nantes
    Presse Med 32:30-2. 2003
    ..However, till now, the impact of educational and preventive campaigns with regard to sun exposure, which plays a major role in the development of a melanoma, are still insufficient..
  80. ncbi [Autoimmunity induced by low doses of interferon in melanoma stage I]
    F Ballanger
    Clinique Dermatologique, , Nantes
    Ann Dermatol Venereol 133:543-8. 2006
    ..In our study, however auto immunity markers do not appear as factors of severity of evolution of the melanoma or predictive factors...
  81. ncbi Infantile acne: a retrospective study of 16 cases
    Muriel Hello
    Department of Dermatology, Nantes University Hospital, Nantes, France
    Pediatr Dermatol 25:434-8. 2008
    ..On the basis of the frequency of scarring, and the severity and average duration of lesions, the use of oral retinoids in severe infantile acne warrants evaluation...
  82. ncbi Acne: physical treatment
    Brigitte Dreno
    Department of Dermatology, Nantes, France
    Clin Dermatol 22:429-33. 2004
    ..Different physical treatments may be used in acne therapy. The main indications are for treating retentional lesions (open and comedones), inflamed lesions, and scars...
  83. ncbi Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris
    B Dreno
    Department of Dermatology, CHU Nantes, France
    Dermatology 203:135-40. 2001
    ..CONCLUSION: Minocycline and zinc gluconate are both effective in the treatment of inflammatory acne, but minocycline has a superior effect evaluated to be 17% in our study...
  84. ncbi A tool to evaluate rapidly the quality of clinical trials on topical acne treatment
    J Revuz
    Service de Dermatologie, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Universite Paris XII, Creteil Cedex, France
    J Eur Acad Dermatol Venereol 22:800-6. 2008
    ..Regarding the application of evidence-based medicine in clinical practice, this tool is user friendly and should facilitate the updating of our knowledge...
  85. ncbi Prognostic factors in Sézary syndrome: a study of 28 patients
    P Foulc
    Clinique Dermatologique, CHU Hotel-Dieu, 1 Place Alexis Ricordeau, 44000 Nantes, France
    Br J Dermatol 149:1152-8. 2003
    ..This seems consistent with a marked immune deficit during severe forms of SS...
  86. ncbi Diagnosis of primary cutaneous B-cell lymphoma by immunohistochemical and in situ hybridization methods
    Stephanie Mendes
    Department of Dermatology, University Hospital of Nantes, France
    Acta Derm Venereol 83:167-70. 2003
    ..It is concluded that kappa or lambda chain in situ hybridization is an interesting complementary technique to detect monoclonal B cells, if the immunohistochemical technique is negative...
  87. ncbi An epidemiological study of acne in female adults: results of a survey conducted in France
    F Poli
    Hĵpital Henri Mondor, Service de Dermatologie, Creteil, France
    J Eur Acad Dermatol Venereol 15:541-5. 2001
    ..For most patients, acne did not severely impair their quality of life. CONCLUSION: This study shows a prevalence of acne in 41% of women in the general population. A high proportion of these acne cases are late onset acne...
  88. ncbi Prognostic value of tyrosinase reverse-transcriptase polymerase chain reaction in metastatic melanoma
    G Quereux
    Department of Dermatology, CHU, Nantes, France
    Dermatology 203:221-5. 2001
    ..CONCLUSION: The prognostic value of this method could be improved by combining it with PCR of other melanoma markers (Melan A, Mage 3) or assays of serum markers (S 100 protein or lactate dehydrogenase)...
  89. ncbi Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans
    L Martin
    Department of Dermatology, Hôpital Porte Madeleine, CHR Orleans, 45032 Orleans Cedex 1, France
    Br J Dermatol 153:932-6. 2005
    ..Some cases of dermatofibrosarcoma protuberans (DFSP) do not protrude above the skin...
  90. ncbi Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes
    V Jarrousse
    INSERM U601, 9 quai Moncousu, 44093 Nantes Cedex 01, France
    Arch Dermatol Res 299:441-7. 2007
    ..acnes extracts are directly able to modulate the differentiation of keratinocytes suggesting that this bacteria play a role not only in the development of inflammatory acne lesions but also in the formation of the microcomedo...
  91. ncbi Heredity: a prognostic factor for acne
    F Ballanger
    Department of Dermatology, , FR-44035 Nantes, France
    Dermatology 212:145-9. 2006
    ..CONCLUSION: This study confirms the importance of heredity as a prognostic factor for acne. Family history of acne is associated with earlier occurrence of acne, increased number of retentional lesions and therapeutic difficulties...
  92. ncbi Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
    S Leroy
    INSERM U463, Nantes, France
    Br J Dermatol 144:1016-23. 2001
    ..CONCLUSIONS: Induction of keratinocyte IL-15 expression appears to be a feature of CTCL. The factors stimulating such an expression remain unknown...
  93. ncbi Evaluation of a 1-h exposure time to mechlorethamine in patients undergoing topical treatment
    P Foulc
    Department of Dermatology, CHU Nantes, 1 Place Alexis Ricordeau, 44035 Nantes cedex 1, France
    Br J Dermatol 147:926-30. 2002
    ..Therapeutic response was decreased appreciably by short-term application as compared with results in the literature...
  94. ncbi Modulation in vitro of keratinocyte integrins by interferon-alpha and interferon-gamma
    Isabelle Tenaud
    Laboratory of Immuno Dermatology, INSERM U463, Nantes, France
    Int J Dermatol 41:836-40. 2002
    ..In the same way, integrins are adhesion molecules which regulate keratinocyte proliferation and differentiation...
  95. ncbi Erythromycin-resistance of cutaneous bacterial flora in acne
    B Dreno
    Department of Dermatology, CHU Nantes, Hotel Dieu, Pl A Ricordeau, 44093 Nantes Cedex 1, France
    Eur J Dermatol 11:549-53. 2001
    ..However, zinc combined with erythromycin in vitro did not modify the erythromycin MIC. This first French study on bacterial resistance to erythromycin in acne patients confirms the results of studies performed in other countries...
  96. ncbi Pathogenetic mechanisms of vitiligo in a patient with Sézary syndrome
    A C Knol
    INSERM U601, , 9 quai Moncousu, 44093 Nantes Cedex 01, France
    Br J Dermatol 153:1207-12. 2005
    ..The role of interferon in the induction of this T-lymphocyte subpopulation is discussed...
  97. ncbi [Viruses involved in allograft recipients'cutaneous carcinomas]
    E Parant
    Clinique Dermatologique, , Place Alexis Ricordeau, 44093 Nantes
    Ann Dermatol Venereol 128:871-5. 2001
    ..Moreover, for the first time, cytomegalovirus DNA was detected in carcinomas of renal allograft recipients with a higher frequency in the patients with multiple carcinomas...
  98. ncbi Loss of oncostatin M receptor beta in metastatic melanoma cells
    A Lacreusette
    INSERM, U601, Groupe de Recherche Cytokines et Récepteurs, Institut de Biologie, Nantes, France
    Oncogene 26:881-92. 2007
    ..Altogether, our results suggest a role for OSM in the prevention of melanoma progression and that metastatic melanoma cells could escape this growth control by the epigenetic silencing of OSMRbeta...
  99. ncbi Overexpression of MMP-2 and MMP-9 in squamous cell carcinomas of immunosuppressed patients
    N Chebassier
    Laboratory of Dermato-Immunology, INSERM U463, 9 quai Moncousu, 44093 Nantes Cedex 01, France
    Arch Dermatol Res 294:124-6. 2002